文献速递脑血管病外科

Pipeline装置与弹簧圈栓塞治疗小于10毫米未破裂动脉瘤的疗效比较分析

Comparative effectiveness analysis of Pipeline device versus coiling in unruptured aneurysms smaller than 10 mm.
PubMed 文献 · J Neurosurg · 2019-01-11

本研究采用决策分析模型模拟小于10毫米未破裂动脉瘤患者接受弹簧圈栓塞、支架辅助弹簧圈栓塞或Pipeline栓塞装置(PED)治疗的结局。基础案例分析显示PED的健康获益(17.48质量调整生命年[QALYs])高于弹簧圈栓塞(17.44 QALYs)和支架辅助弹簧圈栓塞(17.36 QALYs)。作者结论认为PED可能因再治疗率较低而具有更高健康获益,但需更长期随访研究记录复发率和再治疗率以评估成本效益。

要点

  • 在50岁男性基础案例分析中,PED的健康获益为17.48 QALYs,高于弹簧圈栓塞的17.44 QALYs和支架辅助弹簧圈栓塞的17.36 QALYs。
  • 概率敏感性分析中,PED在10,000次迭代中的6020次为更优选择。
  • 当PED再治疗率低于9.53%且弹簧圈栓塞再治疗率高于15.6%时,PED为更优策略。

核心结论

  • 随着PED用于治疗小型未破裂动脉瘤的增加,本研究表明与单纯弹簧圈栓塞和支架辅助技术相比,PED可能因再治疗率较低而具有更高的健康获益。
  • 需要更长期的随访研究来记录弹簧圈栓塞和PED后的复发率和再治疗率,以评估这些策略的成本效益。

研究设计与样本

  • 采用马尔可夫模型方法的决策分析研究,模拟小型未破裂动脉瘤患者接受血管内弹簧圈栓塞、支架辅助弹簧圈栓塞(SAC)或PED置入治疗。
  • 输入概率来自既往文献,并进行单因素、双因素和概率敏感性分析以评估模型和输入参数的不确定性。

主要发现

  • 50岁男性基础案例计算显示PED的健康获益(17.48 QALYs)高于弹簧圈栓塞(17.44 QALYs)或SAC(17.36 QALYs)。
  • 在概率敏感性分析的10,000次迭代中,PED在6020次中为更优选择。
  • 当PED再治疗率低于9.53%且弹簧圈栓塞再治疗率高于15.6%时,PED为更优策略。
  • 在改变两种治疗方式再治疗率的双因素敏感性分析中,当PED再治疗率比弹簧圈栓塞再治疗率低约14%时,PED是更有利的治疗策略;否则弹簧圈栓塞更有效。
  • 当SAC的不良结局风险低于其报告当前值的70%时,SAC可能优于PED。

关键数值与推荐

  • PED再治疗率低于9.53%且弹簧圈栓塞再治疗率高于15.6%时,PED为更优策略。
  • PED再治疗率比弹簧圈栓塞再治疗率低约14%时,PED为更有利的治疗策略;否则弹簧圈栓塞更有效。
  • SAC的不良结局风险低于其报告当前值的70%时,SAC可能优于PED。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需要更长期的随访研究来记录弹簧圈栓塞和PED后的复发率和再治疗率,以评估这些策略的成本效益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Both endovascular coiling and the Pipeline embolization device (PED) have been shown to be safe and clinically effective for treatment of small (< 10 mm) aneurysms. The authors conducted a comparative effectiveness analysis to compare the utility of these treatment methods in terms of health benefits. METHODS: A decision-analytical study was performed with Markov modeling methods to simulate patients with small unruptured aneurysms undergoing endovascular coiling, stent-assisted coiling (SAC), or PED placement for treatment. Input probabilities were derived from prior literature, and 1-way, 2-way, and probabilistic sensitivity analyses were performed to assess model and input parameter uncertainty. RESULTS: The base case calculation for a 50-year-old man reveals PED to have a higher health benefit (17.48 quality-adjusted life years [QALYs]) than coiling (17.44 QALYs) or SAC (17.36 QALYs). PED is the better option in 6020 of the 10,000 iterations in probabilistic sensitivity analysis. When the retreatment rate of PED is lower than 9.53%, and the coiling retreatment is higher than 15.6%, PED is the better strategy. In the 2-way sensitivity analysis varying the retreatment rates from both treatment modalities, when the retreatment rate of PED is approximately 14% lower than the retreatment rate of coiling, PED is the more favorable treatment strategy. Otherwise, coiling is more effective. SAC may be better than PED when the unfavorable outcome risk of SAC is lower than 70% of its reported current value. CONCLUSIONS: With the increasing use of PEDs for treatment of small unruptured aneurysms, the current study indicates that these devices may have higher health benefits due to lower rates of retreatment compared to both simple coiling and stent-assisted techniques. Longer follow-up studies are needed to document the rates of recurrence and retreatment after coiling and PED to assess the cost-effectiveness of these strategies.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Malhotra A, Wu X, Miller T, et al. Comparative effectiveness analysis of Pipeline device versus coiling in unruptured aneurysms smaller than 10 mm. J Neurosurg. 2019. PMID: 30641830. doi:10.3171/2018.8.JNS181080

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。